<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Psychol</journal-id><journal-id journal-id-type="iso-abbrev">Front Psychol</journal-id><journal-id journal-id-type="publisher-id">Front. Psychol.</journal-id><journal-title-group><journal-title>Frontiers in Psychology</journal-title></journal-title-group><issn pub-type="epub">1664-1078</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4866616</article-id><article-id pub-id-type="doi">10.3389/fpsyg.2016.00729</article-id><article-categories><subj-group subj-group-type="heading"><subject>Psychology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Metacognitions Are Associated with Subjective Memory Problems in Individuals on Sick Leave due to Chronic Fatigue </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jacobsen</surname><given-names>Henrik B.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/244014/overview"/></contrib><contrib contrib-type="author"><name><surname>Aasvik</surname><given-names>Julie K.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/224576/overview"/></contrib><contrib contrib-type="author"><name><surname>Borchgrevink</surname><given-names>Petter C.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Landrø</surname><given-names>Nils I.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/691/overview"/></contrib><contrib contrib-type="author"><name><surname>Stiles</surname><given-names>Tore C.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/15733/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Hysnes Rehabilitation Center, St. Olav's University Hospital</institution><country>Trondheim, Norway</country></aff><aff id="aff2"><sup>2</sup><institution>National Competence Center for Pain and Complex Disorders, St. Olav's University Hospital</institution><country>Trondheim, Norway</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Circulation and Medical Imaging, Norwegian University of Science and Technology</institution><country>Trondheim, Norway</country></aff><aff id="aff4"><sup>4</sup><institution>Clinical Neuroscience Research Group, Department of Psychology, University of Oslo</institution><country>Oslo, Norway</country></aff><aff id="aff5"><sup>5</sup><institution>Department of Psychology, Norwegian University of Science and Technology</institution><country>Trondheim, Norway</country></aff><author-notes><fn fn-type="edited-by"><p><text><SENT sid="1" pm="."><plain>Edited by: Lorys Castelli, University of Turin, Italy </plain></SENT>
</text></p></fn><fn fn-type="edited-by"><p><text><SENT sid="2" pm="."><plain>Reviewed by: Christina Karatzaferi, University of St. Mark and St. John, UK; Claudia Cormio, National Cancer Research Institute “Giovanni Paolo II”, Italy </plain></SENT>
</text></p></fn><corresp id="fn001">*Correspondence: Henrik B. Jacobsen <email xlink:type="simple">henrik.b.jacobsen@ntnu.no</email></corresp><fn fn-type="other" id="fn002"><p><text><SENT sid="3" pm="."><plain>This article was submitted to Psychology for Clinical Settings, a section of the journal Frontiers in Psychology </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>7</volume><elocation-id>729</elocation-id><history><date date-type="received"><day>04</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>29</day><month>4</month><year>2016</year></date></history><permissions><copyright-statement>Copyright © 2016 Jacobsen, Aasvik, Borchgrevink, Landrø and Stiles.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Jacobsen, Aasvik, Borchgrevink, Landrø and Stiles</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="4" pm="."><plain>Background: Subjective cognitive impairments are frequent, but poorly understood in patients with chronic fatigue. </plain></SENT>
<SENT sid="5" pm="."><plain>We hypothesized that maladaptive metacognitive beliefs at baseline were associated with baseline subjective cognitive impairments, that they predict subjective cognitive impairments at treatment termination, and that a reduction in maladaptive metacognitive beliefs was associated with less subjective cognitive impairments at treatment termination, independent of changes in fatigue, pain, insomnia, depression, and anxiety. </plain></SENT>
</text></SecTag></p><p><SecTag type="ABS"><text><SENT sid="6" pm="."><plain>Methods: In this non-controlled study, patients (n = 137) on sick leave due to chronic fatigue received a 3.5-week inpatient RTW rehabilitation program. </plain></SENT>
<SENT sid="7" pm="."><plain>Of these patients 69 (50.4%) was referred with a ICPC-2 diagnosis of chronic fatigue. </plain></SENT>
<SENT sid="8" pm="."><plain>Patients completed questionnaires about metacognitive beliefs, somatic complaints, psychological complaints, and cognitive impairments before and after treatment. </plain></SENT>
<SENT sid="9" pm="."><plain>To test the hypotheses we performed paired t-tests of change, as well as seven hierarchical linear regressions. </plain></SENT>
</text></SecTag></p><p><SecTag type="ABS"><text><SENT sid="10" pm="."><plain>Results: Results showed that baseline maladaptive metacognitive beliefs were significantly associated with subjective cognitive impairments at baseline, controlling for symptoms. </plain></SENT>
<SENT sid="11" pm="."><plain>Score on baseline metacognitive beliefs did not predict impairments post-treatment. </plain></SENT>
<SENT sid="12" pm="."><plain>Testing specific maladaptive beliefs, pre-treatment scores on cognitive confidence were associated with subjective cognitive impairments both pre and post-treatment, controlling for symptoms. </plain></SENT>
<SENT sid="13" pm="."><plain>Post-treatment metacognitive beliefs and post-treatment cognitive confidence were associated with post-treatment subjective cognitive impairments, controlling for pre-treatment impairments and pre-treatment metacognitive beliefs, as well as pre and post-scores on symptom measures. </plain></SENT>
</text></SecTag></p><p><SecTag type="ABS"><text><SENT sid="14" pm="."><plain>Conclusion: This study reports associations between maladaptive metacognitive beliefs and subjective cognitive impairments in patients with chronic fatigue. </plain></SENT>
<SENT sid="15" pm="."><plain>Targeting metacognitive beliefs could prove an effective therapeutic intervention for subjective cognitive impairments in these patients. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>metacognition</kwd><kwd>chronic fatigue</kwd><kwd>memory</kwd><kwd>attention</kwd></kwd-group></SecTag><funding-group><award-group><funding-source id="cn001">Helse Midt-Norge<named-content content-type="fundref-id">10.13039/501100004590</named-content></funding-source></award-group></funding-group><counts><fig-count count="0"/><table-count count="3"/><equation-count count="0"/><ref-count count="49"/><page-count count="10"/><word-count count="7639"/></counts></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro" id="s1"><title><text><SENT sid="16" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="17" pm="."><plain>Chronic fatigue syndrome (CFS) is a prevalent condition characterized by persistent mental and somatic fatigue (Loge et al., 1998; McCrone et al., 2003). </plain></SENT>
<SENT sid="18" pm="."><plain>Unfortunately, little ground has been made when it comes to understanding its etiology, agreeing on a case definition, or providing patients with efficacious treatments (Castell et al., 2011). </plain></SENT>
<SENT sid="19" pm="."><plain>This has led to symptom measures often being argued as the best way to classify and investigate these patients (Brurberg et al., 2014). </plain></SENT>
<SENT sid="20" pm="."><plain>One of several criteria for fulfilling a CFS case definition is reporting problems with forgetfulness, increased distractibility, and reduced mental alertness (Fukuda et al., 1994; Jason et al., 2004). </plain></SENT>
<SENT sid="21" pm="."><plain>These subjective cognitive complaints or impairments are part of all popular CFS classifications (Holmes et al., 1988; Sharpe et al., 1991) making them a hallmark of the disorder (Jason et al., 2004). </plain></SENT>
<SENT sid="22" pm="."><plain>Their importance is underlined by 90% of CFS patients rating problems with memory and concentration as a primary concern (Jason et al., 1999). </plain></SENT>
</text></p><p><text><SENT sid="23" pm="."><plain>Memory and concentration are cognitive capabilities usually defined within the overarching term “executive control functioning” (Miyake and Friedman, 2012). </plain></SENT>
<SENT sid="24" pm="."><plain>Executive control includes many aspects such as the control of attention, the capacity to access and manipulate information in long-term memory, as well as monitoring current internal and external states (Funahashi, 2001). </plain></SENT>
<SENT sid="25" pm="."><plain>CFS patients report a perceived inability to perform cognitive tasks and some data indicates that CFS patients have a lowered performance on objective neuropsychological tests (Michiels and Cluydts, 2001). </plain></SENT>
<SENT sid="26" pm="."><plain>However, this objective bias appears to only be present when the tasks are highly demanding (Dobbs et al., 2001; Cook et al., 2007). </plain></SENT>
<SENT sid="27" pm="."><plain>As an example, performance differences between CFS patients and controls are reported on the modified Paced Auditory Serial Attention Test, but not for a simple number recognition task (Cook et al., 2007). </plain></SENT>
<SENT sid="28" pm="."><plain>Subjective cognitive impairments on the other hand, are consistently reported (Cockshell and Mathias, 2014). </plain></SENT>
</text></p><p><text><SENT sid="29" pm="."><plain>Performing demanding cognitive tasks causes mental fatigue (Cook et al., 2007), which here refers to temporary depletion of cognitive resources. </plain></SENT>
<SENT sid="30" pm="."><plain>Within CFS, mental fatigue has documented effects on attention, working memory, and other executive control processes (Boksem and Tops, 2008). </plain></SENT>
<SENT sid="31" pm="."><plain>Hence, evaluation of predicted rewards and costs quickly becomes relevant. </plain></SENT>
<SENT sid="32" pm="."><plain>Most of us tend to loose motivation to perform when the energy costs are believed to outweigh rewards (Boksem and Tops, 2008). </plain></SENT>
<SENT sid="33" pm="."><plain>This means that a subjective cost-benefit analysis of mental fatigue, or subjective impairment, could affect patients' objective ability to efficiently attend to, store and retrieve information when solving mental tasks. </plain></SENT>
</text></p><p><text><SENT sid="34" pm="."><plain>However, such linking of subjective and objective cognitive functioning in CFS is controversial and not straightforward (Cockshell and Mathias, 2014). </plain></SENT>
<SENT sid="35" pm="."><plain>The foremost example of this is lack of a consistent correlation between tests (Wearden and Appleby, 1997), and that both objective performance and perceived problems could be a result of, or influenced by, co-morbid symptoms such as pain, insomnia, depression, and anxiety (Cockshell and Mathias, 2014). </plain></SENT>
<SENT sid="36" pm="."><plain>A recent review argues that subjective and objective measures of cognitive complaints could in fact represent entirely different constructs in these patients (Cockshell and Mathias, 2014). </plain></SENT>
</text></p><p><text><SENT sid="37" pm="."><plain>Subjective cognitive evaluation can be argued as a form of metacognitive monitoring (Shimamura, 2000). </plain></SENT>
<SENT sid="38" pm="."><plain>The concept of metacognitions has become increasingly popular in psychotherapy research, also within CFS (Fernie et al., 2015). </plain></SENT>
<SENT sid="39" pm="."><plain>Metacognitions are popularly defined as “beliefs about thinking” or “cognitions about cognition” (Wells, 2011), and metacognitive theory is concerned with excessive, sustained verbal thinking, and dwelling on negative emotions or symptoms in the form of rumination and/or worry (Nolen-Hoeksema, 2000; Wells, 2011). </plain></SENT>
<SENT sid="40" pm="."><plain>It is a novel perspective associated with symptom severity (Fernie et al., 2015), but targets “perception of” and “dwelling on” symptoms rather than objective changes to metabolism or nociception. </plain></SENT>
<SENT sid="41" pm="."><plain>Hence, intervening on metacognitions might offer a new treatment approach, especially when it comes to subjective cognitive evaluation. </plain></SENT>
</text></p><p><text><SENT sid="42" pm="."><plain>This notion is substantiated by rumination and worry being cognitive processes associated with increased mental fatigue (Querstret and Cropley, 2012). </plain></SENT>
<SENT sid="43" pm="."><plain>Moreover, excessive worry and rumination creates and maintains a specific attention bias toward threats (Nolen-Hoeksema, 2000; Maren, 2007; Browning et al., 2010). </plain></SENT>
<SENT sid="44" pm="."><plain>This bias has within metacognitive theory been coined the “cognitive attentional syndrome” (CAS; Wells, 2011). </plain></SENT>
<SENT sid="45" pm="."><plain>It is there described as a metacognitive process, which maintains and exacerbates depression and anxiety. </plain></SENT>
<SENT sid="46" pm="."><plain>However, the CAS may prove relevant in CFS as well (Maher-Edwards et al., 2011; Fernie et al., 2015), especially considering data showing CFS patients interpreting more bodily sensations as sign of physical disease, compared to depressed and healthy controls (Dendy et al., 2001). </plain></SENT>
<SENT sid="47" pm="."><plain>Moreover, a study investigating such selective attention show CFS patients having a significant bias toward health-threatening information (Hou et al., 2008). </plain></SENT>
</text></p><p><text><SENT sid="48" pm="."><plain>The theoretical model outlining the development and maintenance of CAS is the Self-Regulatory Executive Function (S-REF) model (Wells and Matthews, 1996; Wells, 2011). </plain></SENT>
<SENT sid="49" pm="."><plain>This model provides a conceptualization of how metacognitive and cognitive factors could be involved in the top-down control of disorders. </plain></SENT>
<SENT sid="50" pm="."><plain>A central premise in this model is that all individuals have positive and negative beliefs about thinking that influences their appraisals (e.g., “I must worry in order to be prepared” or “I cannot control my thoughts”). </plain></SENT>
<SENT sid="51" pm="."><plain>Another premise is that we have implicit procedural metacognitions or “thinking skills” such as heuristics that influence and shape both our cognition and behavior (Wells and Matthews, 1996; Wells, 2011). </plain></SENT>
</text></p><p><text><SENT sid="52" pm="."><plain>Investigating subjective cognitive impairments in chronic fatigue and whether these are associated with dysfunctional metacognitive beliefs, may further our understanding and treatment of these complaints. </plain></SENT>
<SENT sid="53" pm="."><plain>As of now, there are no studies investigating this association, but one study showcased the potential relevance of maladaptive metacognitive beliefs in patients with CFS (Fernie et al., 2015). </plain></SENT>
</text></p><p><text><SENT sid="54" pm="."><plain>It is particularly interesting to see if maladaptive metacognitive beliefs are associated with subjective cognitive complaints independent of symptoms. </plain></SENT>
<SENT sid="55" pm="."><plain>Subjective cognitive impairments have previously been reported to predict quality of life and function in CFS, irrespective of co-morbid symptoms (Ray et al., 1997). </plain></SENT>
</text></p><p><text><SENT sid="56" pm="."><plain>Testing the independent effect of metacognitions is also important for treatment development. </plain></SENT>
<SENT sid="57" pm="."><plain>Several promising treatment manuals for metacognitive therapy exist, which could easily be adapted to fit CFS, either as a stand-alone therapy, or as an addition to graded exercise therapy or traditional cognitive therapy. </plain></SENT>
<SENT sid="58" pm="."><plain>Thus, an investigation of metacognitive beliefs and their association to subjective cognitive complaints in patients with chronic fatigue is warranted. </plain></SENT>
</text></p><p><text><SENT sid="59" pm="."><plain>The main aim of this study is to investigate the association of metacognitive beliefs to subjective cognitive impairments in a population reporting chronic fatigue. </plain></SENT>
<SENT sid="60" pm="."><plain>We hypothesize that maladaptive metacognitive beliefs are associated with subjective cognitive impairments at baseline, controlling for symptoms of fatigue, pain, insomnia, depression, and anxiety. </plain></SENT>
<SENT sid="61" pm="."><plain>Moreover, we hypothesize that maladaptive metacognitive beliefs at the start of treatment will predict subjective cognitive impairments at treatment end. </plain></SENT>
<SENT sid="62" pm="."><plain>We also hypothesize that a reduction in maladaptive metacognitive beliefs during treatment is associated with less subjective cognitive impairments at treatment termination, controlling for the aforementioned symptoms. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="methods" id="s2"><title><text><SENT sid="63" pm="."><plain>Methods </plain></SENT>
</text></title><sec><title><text><SENT sid="64" pm="."><plain>Setting and participants </plain></SENT>
</text></title><p><text><SENT sid="65" pm="."><plain>This study had a pre-post design and was conducted between January 2012 and June 2013 through a 3, 5-week in-patient, Return-To-Work (RTW) occupational rehabilitation program at Hysnes Rehabilitation Center, St. Olav's University Hospital, Trondheim, Norway. </plain></SENT>
<SENT sid="66" pm="."><plain>In Norway a work week includes working Monday through Friday, or 5 days of work of 7, 5 h each. </plain></SENT>
<SENT sid="67" pm="."><plain>A work week is then 37, 5 h in total. </plain></SENT>
<SENT sid="68" pm="."><plain>Since the program lasted 3 work weeks and 2 work days, it consisted of a total of 17, 7, 5-h workdays during which there was an active intervention from the institution. </plain></SENT>
<SENT sid="69" pm="."><plain>The intervention was shaped this way to emulate a normal work week making the transition to work life easier for the patients. </plain></SENT>
<SENT sid="70" pm="."><plain>The choice of an inpatient setting for this program was due to geographical challenges specific to Norway. </plain></SENT>
<SENT sid="71" pm="."><plain>However, the treatment delivered did not exceed that of a day-based outpatient program with regard to hours and available personnel (total availability and treatment was 6.5 h from 8:30 a.m. to 3:00 p.m.). </plain></SENT>
<SENT sid="72" pm="."><plain>For details about the intervention see Fimland et al. (2014). </plain></SENT>
</text></p><p><text><SENT sid="73" pm="."><plain>Prior to the enrolment in this program, the patients had been referred from their general practitioner and examined by an outpatient multidisciplinary team consisting of a physician, a psychologist, and a physiotherapist. </plain></SENT>
<SENT sid="74" pm="."><plain>This team evaluated whether the referred patients met the requirements for participating in the RTW-program, which included, but were not limited to the inclusion and exclusion criteria for the current study. </plain></SENT>
<SENT sid="75" pm="."><plain>Before beginning the rehabilitation program, all patients were asked to complete different questionnaires through an internet-administrated self-report survey. </plain></SENT>
<SENT sid="76" pm="."><plain>At the end of the study, which coincided with the end of the rehabilitation program, the patients again answered several questionnaires. </plain></SENT>
</text></p><p><text><SENT sid="77" pm="."><plain>The inclusion criteria for the study were age (18 to 59 years) and having been on sick leave for at least 8 weeks due to fatigue. </plain></SENT>
<SENT sid="78" pm="."><plain>Further, participants should have self-defined goals of increasing labor participation, to be adequately assessed and treated beforehand for any specific illnesses, and be able to attend a rehabilitation program from 8:30 to 3:00 p.m. all weekdays. </plain></SENT>
<SENT sid="79" pm="."><plain>The exclusion criteria were severe mental illness (ongoing mania, psychosis or suicidal ideation), substance abuse and addiction or pregnancy. </plain></SENT>
<SENT sid="80" pm="."><plain>Moreover, patients who could not communicate in Norwegian or who needed 24-h personal assistance were not eligible. </plain></SENT>
</text></p><p><text><SENT sid="81" pm="."><plain>To be eligible for this study, participants had to report a score of five or more on the fatigue questionnaire, a cut-off validated through previous studies of Norwegian adults (Loge et al., 1998). </plain></SENT>
<SENT sid="82" pm="."><plain>Moreover, to be included in all the planned steps of analyses, the patients could not have any missing data on any of the independent variables or covariates targeted in the subsequent multivariable analyses. </plain></SENT>
<SENT sid="83" pm="."><plain>Hence, the study population consisted of patients meeting these criteria who upon inclusion in the program gave their informed consent. </plain></SENT>
</text></p><p><text><SENT sid="84" pm="."><plain>The Regional Committee for Ethics in Medical Research approved this study and it was conducted in accordance with the declaration of Helsinki. </plain></SENT>
<SENT sid="85" pm="."><plain>The study was registered in clinicaltrials.gov (ID: NCT01568970). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="86" pm="."><plain>The rehabilitation program </plain></SENT>
</text></title><p><text><SENT sid="87" pm="."><plain>Details on the rehabilitation program are published elsewhere (Fimland et al., 2014). </plain></SENT>
<SENT sid="88" pm="."><plain>In brief, the program used a combination of group treatment (8 patients per group) and individual approaches to facilitate rehabilitation. </plain></SENT>
<SENT sid="89" pm="."><plain>The participants were organized with activities through 7-h workdays and the program lasted for a total of 17 workdays with Acceptance and Commitment Therapy (ACT) as the overarching treatment model. </plain></SENT>
<SENT sid="90" pm="."><plain>Therapists targeted three areas of rehabilitation: mental training, physical training, and work-related problem solving. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="91" pm="."><plain>Measures </plain></SENT>
</text></title><p><text><SENT sid="92" pm="."><plain>The participant's demographics were reported through a standardized set of questions validated for a large Norwegian cohort (Holmen et al., 2003), which is also detailed in previous studies (Jacobsen et al., 2014; Kallestad et al., 2015). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="93" pm="."><plain>Dependent variable </plain></SENT>
</text></title><p><text><SENT sid="94" pm="."><plain>Subjective cognitive complaints were reported using The Everyday Memory Questionnaire-Revised (EMQ) (Royle and Lincoln, 2008). </plain></SENT>
<SENT sid="95" pm="."><plain>The EMQ-Revised is a 13-item measure with two main factors of retrieval and attentional tracking, reduced from an original 34-item questionnaire (Royle and Lincoln, 2008). </plain></SENT>
<SENT sid="96" pm="."><plain>Reliability tests on the EMQ have shown a strong internal reliability, with a Cronbachs' Alfa score of.89. </plain></SENT>
<SENT sid="97" pm="."><plain>Each question is rated on a 5-point scale ranging from A, scored as one—“Once or less in the last month,” to E, scored as five—“Once or more in a day.” These items are summed and give an ordinal scale with a range of 0 to 64. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="98" pm="."><plain>Independent variables and covariates </plain></SENT>
</text></title><p><text><SENT sid="99" pm="."><plain>The Chalder Fatigue Questionnaire (Chalder et al., 1993) consists of eleven questions asking about physical and mental fatigue and is frequently used to measure symptoms in chronic fatigue patients. </plain></SENT>
<SENT sid="100" pm="."><plain>Each item has four response categories (0-4), which are scored bi-modally 0-0-1-1. </plain></SENT>
<SENT sid="101" pm="."><plain>When scored, the 11 items are summed and gives each participant a score on a scale of 0–11. </plain></SENT>
<SENT sid="102" pm="."><plain>This eleven-item scale has been validated for a Norwegian adult population with a cut-off on symptom intensity ≥5. </plain></SENT>
<SENT sid="103" pm="."><plain>Cronbach's alpha has been calculated for all items (range 0.88–0.90). </plain></SENT>
<SENT sid="104" pm="."><plain>Split half reliability has also been calculated (0.86 and 0.85, respectively) (Loge et al., 1998). </plain></SENT>
</text></p><p><text><SENT sid="105" pm="."><plain>The Metacognitions Questionnaire-30 (MCQ-30; Wells and Cartwright-Hatton, 2004) asks about metacognitive beliefs through 30 items, compromising five subscales: (1) Positive beliefs about worry (e.g., “Worrying helps me cope”); (2) Negative beliefs about uncontrollability and danger of worry (e.g., “When I start worrying I cannot stop”); (3) Cognitive confidence (e.g., “I have a poor memory”); (4) Need to control thoughts (e.g., “Not being able to control my thoughts is a sign of weakness”); (5) Cognitive self-consciousness (e.g., “I pay close attention to the way my mind works”). </plain></SENT>
<SENT sid="106" pm="."><plain>Items are scored from 1 to 4 (“do not agree,” “agree slightly,” “agree moderately,” “agree very much”), and adding up individual subscale items scores the subscales. </plain></SENT>
<SENT sid="107" pm="."><plain>Cronbach's alpha coefficients for these subscales range from 0.72 to 0.93, with test-retest correlations of: 0.75 (total score), 0.79 (positive beliefs), 0.59 (uncontrollability/danger), 0.69 (cognitive confidence), 0.74 (need for control), and 0.87 (cognitive self-consciousness; Wells and Cartwright-Hatton, 2004). </plain></SENT>
</text></p><p><text><SENT sid="108" pm="."><plain>The Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 1983) asks about symptoms of anxiety and depression. </plain></SENT>
<SENT sid="109" pm="."><plain>The fourteen-item scale with each item ranging from 0 to 3 yields separate scores for anxiety and depression, which are then summed and used as an ordinal scale. </plain></SENT>
<SENT sid="110" pm="."><plain>In a review of HADS in Norwegian adults the correlations between the two subscales varied from 0.40 to 0.74 (mean 0.56). </plain></SENT>
<SENT sid="111" pm="."><plain>Cronbach's alpha for HADS-A varied from 0.68 to 0.93 (mean 0.83) and for HADS-D from 0.67 to 0.90 (mean 0.82; Bjelland et al., 2002). </plain></SENT>
</text></p><p><text><SENT sid="112" pm="."><plain>The Insomnia Severity Index (Bastien et al., 2001; ISI) is a seven-item questionnaire assessing sleep problems. </plain></SENT>
<SENT sid="113" pm="."><plain>A 5-point (0–4) scale, rated difficulties falling asleep, night-time awakenings, early morning awakenings, impairment of daytime functioning due to sleep problems, notice ability of impairments, distress or worry caused by sleep difficulties, and dissatisfaction with sleep. </plain></SENT>
<SENT sid="114" pm="."><plain>The items were summed; giving a scale of 0–28, where ≥15 was used as a moderate cut-off indicating sleep problems. </plain></SENT>
<SENT sid="115" pm="."><plain>This cut-off has been validated in previous studies and the internal consistency of the ISI was reported to be 0.74 (Morin et al., 2011). </plain></SENT>
</text></p><p><text><SENT sid="116" pm="."><plain>Chronic pain was measured with an item from Short Form-8 (Ware et al., 2001) asking “How much bodily pain have you had the last week?” (None, very mild, mild, moderate, severe, and very severe). </plain></SENT>
<SENT sid="117" pm="."><plain>This scale has been validated as a self-report measure of chronic pain in Norwegian populations. </plain></SENT>
<SENT sid="118" pm="."><plain>As this is a one-item measurement, alpha values are not applicable. </plain></SENT>
<SENT sid="119" pm="."><plain>The item has been shown to have an intra-class correlation coefficient of 0.66 (95% CI 0.65 to 0.67; Landmark et al., 2012). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="120" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="121" pm="."><plain>Demographical data from participants was analyzed using frequencies (dichotomous variables) and means (ordinal variables) with standard deviations. </plain></SENT>
<SENT sid="122" pm="."><plain>Paired t-tests were performed to investigate significant change from pre to post-treatment on subjective cognitive impairments, maladaptive metacognitions, insomnia, fatigue, pain, depression, and anxiety. </plain></SENT>
</text></p><p><text><SENT sid="123" pm="."><plain>To test for associations between maladaptive metacognitive beliefs (MCQ-30) and subjective cognitive impairments at baseline, we performed two hierarchical linear regression models: First, using subjective cognitive impairments pre-treatment as a dependent variable we performed a hierarchical regression model with two steps. </plain></SENT>
<SENT sid="124" pm="."><plain>In step one, we entered participants' sex and age, and in step two we entered pre-treatment MCQ-30 sum total score. </plain></SENT>
<SENT sid="125" pm="."><plain>Then, we performed a hierarchical linear regression with three steps. </plain></SENT>
<SENT sid="126" pm="."><plain>In step one, we entered participants' sex and age, and in step two we entered pre-treatment scores on the five symptom measures. </plain></SENT>
<SENT sid="127" pm="."><plain>In step three we entered pre-treatment MCQ-30 sum total score. </plain></SENT>
</text></p><p><text><SENT sid="128" pm="."><plain>Next, we performed a third hierarchical regression model testing the associations of the five subscales of MCQ-30 (cognitive confidence, need to control thoughts, positive beliefs, danger/uncontrollability and cognitive consciousness) with subjective cognitive impairments. </plain></SENT>
<SENT sid="129" pm="."><plain>In step one, we entered participants' sex and age, and in step two we entered pre-treatment scores on symptom measures. </plain></SENT>
<SENT sid="130" pm="."><plain>In step three we entered pre-treatment scores on cognitive confidence need to control thoughts, positive beliefs, danger/uncontrollability, and cognitive consciousness. </plain></SENT>
</text></p><p><text><SENT sid="131" pm="."><plain>To test whether maladaptive metacognitive beliefs (MCQ-30) at treatment start were associated with subjective cognitive impairments at treatment termination, we performed a hierarchical linear regression using subjective cognitive impairments post-treatment as a dependent variable. </plain></SENT>
<SENT sid="132" pm="."><plain>In this regression model we entered sex and age in step one, in step two we entered pre-treatment values for subjective cognitive impairments. </plain></SENT>
<SENT sid="133" pm="."><plain>In step three we entered pre-treatment sum total scores for MCQ-30. </plain></SENT>
</text></p><p><text><SENT sid="134" pm="."><plain>To test whether a reduction in maladaptive metacognitive beliefs (MCQ-30) were associated with change in subjective cognitive impairments, we added fourth step in the hierarchical linear regression using subjective cognitive impairments at treatment termination as the dependent variable. </plain></SENT>
<SENT sid="135" pm="."><plain>We entered sex and age in step one, in step two we entered pre-treatment scores for subjective cognitive impairments, in step three we entered pre-treatment sum total score for MCQ-30. </plain></SENT>
<SENT sid="136" pm="."><plain>In step four, we entered the MCQ-30 sum total score at treatment end. </plain></SENT>
</text></p><p><text><SENT sid="137" pm="."><plain>To test whether maladaptive metacognitive beliefs (MCQ-30) was associated with subjective cognitive impairments (EMQ) controlling for levels of fatigue, pain, insomnia, depression, and anxiety, we performed a hierarchical linear regression using subjective cognitive impairments at treatment termination as the dependent variable. </plain></SENT>
<SENT sid="138" pm="."><plain>We entered sex and age in step one, in step two we entered pre-scores for EMQ, and in step three we entered pre-treatment sum total scores on MCQ-30. </plain></SENT>
<SENT sid="139" pm="."><plain>In step four we entered pre-treatment scores on the five symptom measures. </plain></SENT>
<SENT sid="140" pm="."><plain>In step five we entered post-treatment sum total scores for MCQ-30 and in step six we entered post-treatment scores on the five symptom measures. </plain></SENT>
</text></p><p><text><SENT sid="141" pm="."><plain>To test whether the subscales of the maladaptive metacognitive beliefs (MCQ-30) questionnaire were associated with subjective cognitive impairments (EMQ) controlling for levels of fatigue, pain, insomnia, depression, and anxiety, we performed a hierarchical linear regression using subjective cognitive impairments at treatment termination as the dependent variable. </plain></SENT>
<SENT sid="142" pm="."><plain>We entered sex and age in step one, in step two we entered pre-scores for EMQ, and in step three we entered pre-treatment scores on the subscales of MCQ-30. </plain></SENT>
<SENT sid="143" pm="."><plain>In step four we entered pre-treatment scores on the five symptom measures. </plain></SENT>
<SENT sid="144" pm="."><plain>In step five we entered post-treatment scores on the subscales of MCQ-30 and in step six we entered post-treatment scores on the five symptom measures. </plain></SENT>
</text></p><p><text><SENT sid="145" pm="."><plain>All analyses were performed using the Statistical Package for the Social Sciences (SPSS version 22.0; IBM Corporation, Armonk, NY, USA). </plain></SENT>
<SENT sid="146" pm="."><plain>In all regressions we estimated correlations and colinearity in order to ensure the validity of the models. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results" id="s3"><title><text><SENT sid="147" pm="."><plain>Results </plain></SENT>
</text></title><sec><title><text><SENT sid="148" pm="."><plain>Population demographics </plain></SENT>
</text></title><p><text><SENT sid="149" pm="."><plain>One hundred and eighty-one participants were included in the current study. </plain></SENT>
<SENT sid="150" pm="."><plain>Of these 181 participants, 137 had no missing data, were available for multivariable analysis and t-tests, and represented the study population. </plain></SENT>
<SENT sid="151" pm="."><plain>All participants reported fatigue above the chosen cut off. </plain></SENT>
<SENT sid="152" pm="."><plain>They were predominantly female (80.3%) with a mean age of 43.6 (SD 9.4) years, and with education at a high school level or above (87.6%). </plain></SENT>
<SENT sid="153" pm="."><plain>For an overview of participant characteristics, see Table 1. </plain></SENT>
<SENT sid="154" pm="."><plain>Paired t-tests of change for subjective cognitive impairments and maladaptive metacognitive beliefs are presented in Table 2. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><text><SENT sid="155" pm="."><plain>Characteristics of all included participants (n = 137) self-reporting clinically significant physical and mental fatigue when starting inpatient vocational rehabilitation. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>Demographics </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>Male </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>Female </plain></SENT>
</text></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>Sex (n) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>19.7% (27) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>80.3% (110) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>Age (SD) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>41.0 (11.8) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>41.1 (9.2) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>Height—cm (SD) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="166" pm="."><plain>180.4 (8.1) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="167" pm="."><plain>166.8 (5.9) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="168" pm="."><plain>Weight—kg (SD) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="169" pm="."><plain>88.3 (15.7) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="170" pm="."><plain>76.0 (16.4) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>BMI (SD) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain>27.0 (4.0) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>27.3 (5.6) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>Diagnosed chronic fatigue in ICPC-2: A04 or P29 (n) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>55.6% (15) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>49.0% (54) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" colspan="3" style="background-color:#bbbdc0" rowspan="1"><text><SENT sid="177" pm="."><plain>RELATIONSHIP STATUS (n): </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>Married/Living with Partner (n) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>66.6% (18) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain>70.6% (79) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>Single/Divorced/Widowed (n) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>44.4% (9) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>29.4% (33) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" colspan="3" style="background-color:#bbbdc0" rowspan="1"><text><SENT sid="184" pm="."><plain>EDUCATION (n): </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>Less than High School </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="186" pm="."><plain>18.5% (5) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="187" pm="."><plain>18.0% (20) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="188" pm="."><plain>High School </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="189" pm="."><plain>40.7% (11) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="190" pm="."><plain>35.1% (39) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="191" pm="."><plain>Some College/University </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain>29.6% (8) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>40.5% (45) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>Any College/University Degree </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="195" pm="."><plain>11.1% (3) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain>6.3% (7) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" colspan="3" style="background-color:#bbbdc0" rowspan="1"><text><SENT sid="197" pm="."><plain>PSYCHIATRIC DIAGNOSES (n): </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="198" pm="."><plain>SCID diagnosed Anxiety disorders (F40.1 F40.2 F41.0 F41.1 F41.2 F41.9 F45.2) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>7.4% (2) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain>9.7% (11) </plain></SENT>
</text></td></tr><tr style="border-bottom: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>SCID diagnosed Depressive disorders (F32.0 F32.1 F.33.1 F34.1 F43.2) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>7.4% (2) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="203" pm="."><plain>7.1% (8) </plain></SENT>
</text></td></tr><tr style="border-bottom: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="204" pm="."><plain>Self-reported symptoms above cut-off </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="205" pm="."><plain>Male </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="206" pm="."><plain>Female </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="207" pm="."><plain>HADS Depression (n) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="208" pm="."><plain>51.9% (14) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="209" pm="."><plain>42.9% (48) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="210" pm="."><plain>HADS Anxiety (n) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="211" pm="."><plain>55.6% (15) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="212" pm="."><plain>54.9% (62) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="213" pm="."><plain>Chronic Pain (n) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="214" pm="."><plain>59.3% (16) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>78.8% (89) </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain>Sleep Problems (n) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>33.3% (9) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>26.5% (30) </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><p><text><SENT sid="219" pm="."><plain>Categorical characteristics are reported as percent (frequency) and ordinal characteristics as mean (standard deviation). </plain></SENT>
<SENT sid="220" pm="."><plain>Numbers may not add up to 137 because of missing data on some characteristics. </plain></SENT>
<SENT sid="221" pm="."><plain>Percentage is calculated as percentage of total n of the respective sex (male/female). </plain></SENT>
<SENT sid="222" pm="."><plain>F43.2 is categorized as a depressive disorder in this table, however, it could also be classified as an anxiety disorder as it has somewhat overlapping symptoms. </plain></SENT>
<SENT sid="223" pm="."><plain>Some participants have two SCID diagnoses and were categorized by the primary diagnosis. </plain></SENT>
</text></p></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="T2" position="float"><label>Table 2</label><caption><p><text><SENT sid="224" pm="."><plain>Averaged change on outcomes, metacognitive beliefs, fatigue, mental distress (including insomnia) and pain reported by participants' pre-post intervention. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>Variable </plain></SENT>
</text></th><th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1"><text><SENT sid="226" pm="."><plain>Pre-treatment </plain></SENT>
</text></th><th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1"><text><SENT sid="227" pm="."><plain>Post-treatment </plain></SENT>
</text></th><th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;" rowspan="1"><text><SENT sid="228" pm="."><plain>Paired samplest-test </plain></SENT>
</text></th></tr><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>Mean </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>SD </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>Mean </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain>SD </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>t </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>p </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>g </plain></SENT>
</text></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="8" style="background-color:#bbbdc0" rowspan="1"><text><SENT sid="236" pm="."><plain>COGNITIVE MEASURES: </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>Subjective cognitive complaints (EMQ) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>30.8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>12.3 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain>29.8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>12.6 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>1.4 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>0.17 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>0.03 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>MCQ-30 total </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>53.8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>12.2 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>51.0 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>11.2 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>3.9 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>&lt; 0.001 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>0.2 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" colspan="8" style="background-color:#bbbdc0" rowspan="1"><text><SENT sid="253" pm="."><plain>MCQ SUBSCALES: </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>Cognitive confidence </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="255" pm="."><plain>13.1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="256" pm="."><plain>4.6 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="257" pm="."><plain>12.1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="258" pm="."><plain>4.4 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="259" pm="."><plain>3.2 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="260" pm="."><plain>0.002 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="261" pm="."><plain>0.15 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="262" pm="."><plain>Positive beliefs </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="263" pm="."><plain>7.6 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>2.2 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="265" pm="."><plain>7.3 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>1.7 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>1.7 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>0.1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>0.05 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>Cognitive consci. </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>11.8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>3.4 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>11.8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>3.5 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>−0.3 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>0.98 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>0.2 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>Uncontrollability </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>11.0 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>3.7 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>11.5 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>3.8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>−2.0 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>0.05 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>0.2 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>Need to control thoughts </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>9.7 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>3.1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>9.9 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>3.2 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>−0.9 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>0.35 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>0.2 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" colspan="8" style="background-color:#bbbdc0" rowspan="1"><text><SENT sid="294" pm="."><plain>MENTAL DISTRESS, FATIGUE, AND PAIN: </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="295" pm="."><plain>Insomnia (ISI) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="296" pm="."><plain>12.2 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>6.1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="298" pm="."><plain>9.8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="299" pm="."><plain>6.4 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="300" pm="."><plain>5.53 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="301" pm="."><plain>&lt; 0.001 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="302" pm="."><plain>0.38 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>Pain (SF-8) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>3.95 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>1.14 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>3.5 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>1.15 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>4.97 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>&lt; 0.001 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>0.39 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>Depression (HADS) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>7.1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>3.8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>4.9 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>3.4 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>8.0 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>&lt; 0.001 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>0.65 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>Anxiety (HADS) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>8.2 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>4.2 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>6.2 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>3.8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>6.6 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>&lt; 0.001 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>0.50 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>Fatigue (CFQ) </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>9.0 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>1.8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>5.7 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>3.9 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>10.6 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>&lt; 0.001 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>1.08 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><p><text><SENT sid="335" pm="."><plain>All variables were significance tested with a paired t-test and degree of change was described as a Hedges g effect size. </plain></SENT>
</text></p></table-wrap-foot></table-wrap></SecTag></sec><sec><title><text><SENT sid="336" pm="."><plain>Hypothesis 1: Maladaptive metacognitive beliefs are associated with subjective cognitive impairments at baseline </plain></SENT>
</text></title><p><text><SENT sid="337" pm="."><plain>The sum score on maladaptive metacognitive beliefs (MCQ-30) at baseline was significantly associated with the subjective cognitive impairments (EMQ) sum score at baseline (p &lt; 0.0001; t = 4.5; B = 0.34; 95% Confidence Interval of B (CI) = 0.19, 0.49), controlling for sex, age and pre-scores on symptom scales. </plain></SENT>
<SENT sid="338" pm="."><plain>Fatigue score pre-treatment (p &lt; 0.0001; t = 6.4; B = 3; CI = 2.1, 3.9) and depression score pre-treatment (p = 0.03; t = −2.2; B = −0.53; CI = −1, −0.61) were also significantly associated with EMQ sum score at baseline. </plain></SENT>
</text></p><p><text><SENT sid="339" pm="."><plain>Investigating the subscales of MCQ-30, the subscale of cognitive confidence (p &lt; 0.0001; t = 8.2; B = 1.4; CI = 1.1, 1.8) was significantly associated with the EMQ sum score, controlling for pre-treatment symptom scores, as was the pre-score on the chosen fatigue scale (p &lt; 0.0001; t = 3.6; B = 1.7; CI = 0.77, 2.6). </plain></SENT>
<SENT sid="340" pm="."><plain>The subscales of positive beliefs, need to control thoughts, danger and cognitive consciousness were not. </plain></SENT>
<SENT sid="341" pm="."><plain>Zero order correlations between the self-report measures ranged from (−0.2 to 0.6), with cognitive confidence being the highest and need for thought control the lowest. </plain></SENT>
<SENT sid="342" pm="."><plain>Both collinearity tolerance (1.0–0.5) and variance inflation factor values (1.0–2.4) were acceptable in the regression model. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="343" pm="."><plain>Hypothesis 2: Maladaptive metacognitive beliefs pre-treatment are associated with subjective cognitive impairments at treatment termination </plain></SENT>
</text></title><p><text><SENT sid="344" pm="."><plain>A hierarchical regression analysis showed that the pre-treatment sum total score on MCQ-30 was not associated with EMQ sum score post-treatment, when controlling for pre-scores on the EMQ (p = 0.77; t = 0.29; B = 0.17; CI = −0.1, 0.13). </plain></SENT>
</text></p><p><text><SENT sid="345" pm="."><plain>As pre-treatment cognitive confidence was the only subscale associated with pre-treatment score on EMQ, we performed an additional analysis looking specifically at this subscale. </plain></SENT>
<SENT sid="346" pm="."><plain>Pre-treatment scores on cognitive confidence were significantly associated with post-treatment scores on EMQ, controlling for scores on all symptom measures both pre and post-treatment (p &lt; 0.0001; t = −3.8; B = −0.7; CI = −1.1, −0.35). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="347" pm="."><plain>Hypothesis 3: A reduction in metacognitive beliefs post-treatment is associated with less subjective cognitive complaints at treatment termination </plain></SENT>
</text></title><p><text><SENT sid="348" pm="."><plain>Results from a hierarchical regression showed that a reduction on MCQ-30 was significantly associated with a reduced post-treatment score on EMQ, controlling for pre-treatment MCQ-30 scores, fatigue scores (pre-post), pain (pre-post), insomnia severity (pre-post), anxiety and depression (pre-post) (p &lt; 0.0001; t = 3.6; B = 0.35; CI = 0.16, 0.5). </plain></SENT>
<SENT sid="349" pm="."><plain>Analytic details of the regression are presented in Table 3. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T3" position="float"><label>Table 3</label><caption><p><text><SENT sid="350" pm="."><plain>Hierarchical regressions using everyday memory questionnaire (EMQ) post-treatment as a dependent variable and metacognitive questionnaire (MCQ) as an independent variable, controlling for pre-treatment values of EMQ, MCQ, fatigue, pain, insomnia, depressive symptoms and post-treatment values of fatigue, pain and depressive symptoms. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>Variables </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>Beta Coefficient </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>P </plain></SENT>
</text></th><th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1"><text><SENT sid="354" pm="."><plain>95% Confidence Interval </plain></SENT>
</text></th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>Low </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>High </plain></SENT>
</text></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="5" style="background-color:#bbbdc0" rowspan="1"><text><SENT sid="357" pm="."><plain>STEP 1: </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="358" pm="."><plain>Sex </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>−0.127 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>0.165 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>−9.421 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>1.628 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>Age </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>0.097 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>0.286 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>−0.119 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>0.400 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" colspan="5" style="background-color:#bbbdc0" rowspan="1"><text><SENT sid="368" pm="."><plain>STEP 2: </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>Sex </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>−0.080 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>0.142 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>−5.753 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>0.838 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>Age </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>0.048 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>0.374 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>−0.085 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>0.224 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>Pre-treatment EMQ </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>0.798 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>0.000 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>0.691 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>0.906 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" colspan="5" style="background-color:#bbbdc0" rowspan="1"><text><SENT sid="384" pm="."><plain>STEP 3: </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>Sex </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="386" pm="."><plain>−0.080 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="387" pm="."><plain>0.145 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>−5.761 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>0.857 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="390" pm="."><plain>Age </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>0.048 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>0.375 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="393" pm="."><plain>−0.086 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="394" pm="."><plain>0.225 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>Pre-treatment EMQ </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>0.793 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>0.000 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>0.678 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>0.908 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>Pre-treatment MCQ-30 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>0.016 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="402" pm="."><plain>0.785 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>−0.099 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>0.131 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" colspan="5" style="background-color:#bbbdc0" rowspan="1"><text><SENT sid="405" pm="."><plain>STEP 4: </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>Sex </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>−2.761 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>0.125 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>−6.305 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>0.783 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>Age </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>0.086 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>0.288 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>−0.074 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>0.246 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>Pre-treatment EMQ </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>0.775 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>0.000 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>0.642 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>0.907 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>Pre-treatment MCQ-30 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>0.050 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>0.452 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>−0.081 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>0.182 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>Pre-treatment Fatigue </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>0.068 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>0.884 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>−0.850 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="430" pm="."><plain>0.986 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>Pre-treatment Anxiety </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="432" pm="."><plain>−0.204 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="433" pm="."><plain>0.315 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>−0.603 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>0.196 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>Pre-treatment Depression </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="437" pm="."><plain>−0.183 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>0.414 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>−0.626 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>0.260 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>Pre-treatment Pain </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>−0.237 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>0.707 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>−1.487 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>1.012 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>Pre-treatment Insomnia </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>0.169 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>0.189 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>−0.085 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>0.424 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" colspan="5" style="background-color:#bbbdc0" rowspan="1"><text><SENT sid="451" pm="."><plain>STEP 5: </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>Sex </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>−2.337 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>0.158 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>−5.597 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>0.923 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>Age </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>0.095 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>0.204 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>−0.052 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>0.242 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>Pre-treatment EMQ </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="463" pm="."><plain>0.723 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>0.000 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>0.600 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>0.847 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>Pre-treatment MCQ-30 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>−0.207 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>0.014 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>−0.371 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>−0.044 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>Pre-treatment Fatigue </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>0.145 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>0.734 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>−0.699 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>0.989 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>Pre-treatment Anxiety </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>−0.185 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>0.320 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>−0.552 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>0.182 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>Pre-treatment Depression </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>−0.405 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>0.057 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>−0.823 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>0.013 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>Pre-treatment Pain </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>0.224 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>0.704 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>−0.941 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>1.389 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>Pre-treatment Insomnia </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>0.152 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>0.200 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>−0.082 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>0.385 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>Post-treatment MCQ-30 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>0.411 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>0.000 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="500" pm="."><plain>0.235 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="501" pm="."><plain>0.587 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" colspan="5" style="background-color:#bbbdc0" rowspan="1"><text><SENT sid="502" pm="."><plain>STEP 6: </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="503" pm="."><plain>Sex </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>−2.330 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>0.162 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>−5.615 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>0.954 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>Age </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="509" pm="."><plain>0.054 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>0.459 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>−0.091 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="512" pm="."><plain>0.200 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>Pre-treatment EMQ </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>0.728 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>0.000 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>0.608 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>0.849 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>Pre-treatment MCQ-30 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>−0.138 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>0.098 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>−0.302 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>0.026 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>Pre-treatment Fatigue </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>−0.081 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>0.859 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>−0.983 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="527" pm="."><plain>0.821 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="528" pm="."><plain>Pre-treatment Anxiety </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="529" pm="."><plain>0.048 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="530" pm="."><plain>0.822 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="531" pm="."><plain>−0.375 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>0.471 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>Pre-treatment Depression </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="534" pm="."><plain>−0.515 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="535" pm="."><plain>0.030 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="536" pm="."><plain>−0.981 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>−0.050 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="538" pm="."><plain>Pre-treatment Pain </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="539" pm="."><plain>−0.342 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>0.613 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="541" pm="."><plain>−1.678 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>0.993 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="543" pm="."><plain>Pre-treatment Insomnia </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="544" pm="."><plain>−0.041 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>0.783 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="546" pm="."><plain>−0.332 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>0.251 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="548" pm="."><plain>Post-treatment MCQ-30 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>0.347 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="550" pm="."><plain>0.000 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="551" pm="."><plain>0.156 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="552" pm="."><plain>0.538 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="553" pm="."><plain>Post-treatment Fatigue </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="554" pm="."><plain>0.197 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="555" pm="."><plain>0.334 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="556" pm="."><plain>−0.205 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="557" pm="."><plain>0.599 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="558" pm="."><plain>Post-treatment Pain </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="559" pm="."><plain>1.350 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="560" pm="."><plain>0.054 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="561" pm="."><plain>−0.026 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="562" pm="."><plain>2.727 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="563" pm="."><plain>Post-treatment Insomnia </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="564" pm="."><plain>0.182 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="565" pm="."><plain>0.239 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="566" pm="."><plain>−0.123 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="567" pm="."><plain>0.487 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="568" pm="."><plain>Post-treatment Anxiety </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="569" pm="."><plain>−0.581 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="570" pm="."><plain>0.048 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="571" pm="."><plain>−1.156 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="572" pm="."><plain>−0.006 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="573" pm="."><plain>Post-treatment Depression </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="574" pm="."><plain>0.517 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="575" pm="."><plain>0.095 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="576" pm="."><plain>−0.092 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="577" pm="."><plain>1.125 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><p><text><SENT sid="578" pm="."><plain>Everyday memory questionnaire—Revised (EMQ); Metacognitive beliefs questionnaire (MCQ). </plain></SENT>
</text></p></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="579" pm="."><plain>As pre-treatment cognitive confidence was associated with pre-treatment and post-treatment score on EMQ, we again performed an additional analysis looking specifically at this subscale. </plain></SENT>
<SENT sid="580" pm="."><plain>Post-treatment scores on cognitive confidence were significantly associated with post-treatment scores on EMQ, controlling for scores on all symptom measures both pre and post-treatment (p &lt; 0.0001; t = 6.0; B = 1.2; CI = 0.8, 1.7). </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="discussion" id="s4"><title><text><SENT sid="581" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="582" pm="."><plain>This is the first study to report associations between maladaptive metacognitive beliefs and subjective cognitive impairments in chronically fatigued patients. </plain></SENT>
<SENT sid="583" pm="."><plain>Maladaptive metacognitive beliefs were associated with subjective cognitive complaints at baseline. </plain></SENT>
<SENT sid="584" pm="."><plain>Investigating the subscales of MCQ-30, only the scale asking beliefs about cognitive confidence had pre-treatment scores associated with pre-treatment subjective cognitive impairments. </plain></SENT>
<SENT sid="585" pm="."><plain>When looking at whether maladaptive metacognitive beliefs at baseline predicted subjective impairments at treatment end, we found that the sum of MCQ-30 did not predict subjective ratings. </plain></SENT>
<SENT sid="586" pm="."><plain>However, baseline scores on the subscale of cognitive confidence did predict subjective impairments at treatment end. </plain></SENT>
<SENT sid="587" pm="."><plain>Moreover, when testing if a reduction in sum total maladaptive metacognitive beliefs predicted less subjective cognitive impairments at treatment termination, we found a significant association that remained when controlling for baseline subjective cognitive complaints, and pre-post scores on fatigue, pain, insomnia, depression and anxiety. </plain></SENT>
<SENT sid="588" pm="."><plain>This was also the case for a reduction in post-treatment values on the cognitive confidence subscale, indicating that this subscale is particularly relevant in subjective cognitive impairments. </plain></SENT>
</text></p><p><text><SENT sid="589" pm="."><plain>Our finding that baseline metacognitive beliefs concerning cognitive confidence were associated with baseline scores on subjective cognitive complaints is new. </plain></SENT>
<SENT sid="590" pm="."><plain>According to metacognitive theory, metacognitive beliefs about the lack of cognitive confidence will stop adaptive cognitive coping strategies when patients are feeling mental fatigue. </plain></SENT>
<SENT sid="591" pm="."><plain>Indeed, maladaptive metacognitive beliefs about cognitive confidence have been previously been associated with symptom severity in CFS patients (Fernie et al., 2015). </plain></SENT>
<SENT sid="592" pm="."><plain>It is not unlikely then that this association with symptom severity is related to patients' subjective cognitive impairments. </plain></SENT>
<SENT sid="593" pm="."><plain>This claim is substantiated by memory evaluations, such as our judgments of learning abilities being construed as a specific form of metacognitive monitoring (Shimamura, 2000). </plain></SENT>
</text></p><p><text><SENT sid="594" pm="."><plain>The current results may have interesting clinical implications. </plain></SENT>
<SENT sid="595" pm="."><plain>According to recent theorizing in metacognition, cognitive processes are split into two interrelated levels: the meta-level and the object level (Wells, 2011). </plain></SENT>
<SENT sid="596" pm="."><plain>The meta-level contains a cognitive model of the object level, organized according to certain metacognitive principles. </plain></SENT>
<SENT sid="597" pm="."><plain>The meta-level is continuously updated by bottom-up information, and in return controls the object level by providing top-down input, initiating and terminating actions performed by the object level, here understood as an experience of memory or concentration failure. </plain></SENT>
<SENT sid="598" pm="."><plain>Thus, metacognitive regulation is a meta-level system that modulates cognitive processes at the lower level. </plain></SENT>
<SENT sid="599" pm="."><plain>It adds flexibility to cognitive processes, making them less dependent on external cues (Wells, 2011). </plain></SENT>
<SENT sid="600" pm="."><plain>Metacognitions also include self-reflection. </plain></SENT>
<SENT sid="601" pm="."><plain>The ability to recognize ones own maladaptive behavior and perpetuation of symptoms through rumination and worry is an important metacognitive skill (Wells, 2011). </plain></SENT>
<SENT sid="602" pm="."><plain>Self-reflection is largely a product of early life experiences (Dimaggio et al., 2010), and it is difficult to exclude effects from these experiences in the current study. </plain></SENT>
<SENT sid="603" pm="."><plain>However, given that one does not have an adequate metacognitive skill to guide actions when experiencing fatigue, this could be a marker for increased risk for developing long-term fatigue. </plain></SENT>
<SENT sid="604" pm="."><plain>Thus, targeting cognitive confidence both as a screening in patients initially reporting fatigue, subsequently targeting it through metacognitive therapy, could provide us with both a screening tool and a therapeutic intervention. </plain></SENT>
</text></p><p><text><SENT sid="605" pm="."><plain>Our finding that cognitive confidence at baseline predicted subjective cognitive complaints at treatment end is also interesting in this regard. </plain></SENT>
<SENT sid="606" pm="."><plain>Previous data have shown that CFS patient's objective cognitive abilities will vary over a span of 10 weeks (Fuentes et al., 2001). </plain></SENT>
<SENT sid="607" pm="."><plain>It is perhaps indicated here that subjective cognitive evaluations are more stable constructs and therefore a more apt target for intervention. </plain></SENT>
<SENT sid="608" pm="."><plain>The current results suggest that an intervention on maladaptive metacognitions about cognitive confidence would positively influence subjective evaluations over time. </plain></SENT>
<SENT sid="609" pm="."><plain>This would potentially alleviate a concern that 90% of CFS patients rate as primary and debilitating. </plain></SENT>
</text></p><p><text><SENT sid="610" pm="."><plain>The main finding in this study was that a reduction in dysfunctional metacognitive beliefs during treatment was associated with less subjective cognitive impairments at treatment termination. </plain></SENT>
<SENT sid="611" pm="."><plain>This relationship was not affected by symptoms of fatigue, pain, insomnia, anxiety or depression. </plain></SENT>
<SENT sid="612" pm="."><plain>Previous studies have attributed subjective cognitive impairments in CFS to the level of depressive symptoms in patients (Wearden and Appleby, 1997; Cockshell and Mathias, 2014). </plain></SENT>
<SENT sid="613" pm="."><plain>While depressive symptoms and anxiety also showed a significant association with subjective cognitive complaints in the current study population, they did not influence the unique association with maladaptive metacognitive beliefs. </plain></SENT>
</text></p><p><text><SENT sid="614" pm="."><plain>However, the reported relationship between depressive symptoms, anxiety, and subjective cognitive complaints does add a second argument for investigating metacognitions further. </plain></SENT>
<SENT sid="615" pm="."><plain>Metacognitive therapy has previously shown promising results with depressed patients lacking success from traditional cognitive behavioral therapy (CBT; Wells et al., 2012). </plain></SENT>
<SENT sid="616" pm="."><plain>Lack of success with CBT is also the case for many chronic fatigue patients (Castell et al., 2011), and metacognitive therapy could be a feasible option for such cases. </plain></SENT>
<SENT sid="617" pm="."><plain>Moreover, metacognitions have been argued as highly relevant in the development and maintenance of general anxiety disorder (Wells, 2005), a diagnosis often comorbid with CFS (Fischler et al., 1997). </plain></SENT>
</text></p><p><text><SENT sid="618" pm="."><plain>Of particular relevance to the current results is a recent text comparing subjective vs. objective cognitive impairment in chronic fatigue syndrome (Cockshell and Mathias, 2014). </plain></SENT>
<SENT sid="619" pm="."><plain>The authors argue that these are different concepts entirely. </plain></SENT>
<SENT sid="620" pm="."><plain>It seems that subjective impairment is somewhat imprecise and more generic, while objective impairments are closely linked to task difficulty (Cockshell and Mathias, 2014). </plain></SENT>
</text></p><p><text><SENT sid="621" pm="."><plain>Considering this, it is tempting to further speculate on how subjective cognitive complaints could be a prime target for intervention. </plain></SENT>
<SENT sid="622" pm="."><plain>Perseverative thinking in the form of subjective cognitive complaints may lead to physiological changes or prolonged activation, and that in turn might change the patients experience of fatigue and/or disrupt recovery (Brosschot et al., 2006). </plain></SENT>
<SENT sid="623" pm="."><plain>Current stress theory argues that by targeting such perseverative thinking, we might be able to ameliorate not only subjective cognitive complaints, but also the intensity and frequency of fatigue symptoms (Brosschot et al., 2006). </plain></SENT>
</text></p><p><text><SENT sid="624" pm="."><plain>It is important to note that this study used an ACT intervention, not metacognitive therapy. </plain></SENT>
<SENT sid="625" pm="."><plain>While our results imply that targeting metacognitive beliefs through metacognitive therapy is perhaps not necessary to change them, it does not answer whether using a therapy specifically focused on changing metacognitive beliefs could increase this change. </plain></SENT>
<SENT sid="626" pm="."><plain>The reported change in this study is minor, and it could very well be that a targeted metacognitive therapy would have made more impact on the patients'. </plain></SENT>
</text></p></sec></SecTag><SecTag type="DISCUSS"><sec id="s5"><title><text><SENT sid="627" pm="."><plain>Limitations </plain></SENT>
</text></title><p><text><SENT sid="628" pm="."><plain>The current study has some limitations, the foremost being the lack of a control group. </plain></SENT>
<SENT sid="629" pm="."><plain>Another limitation is that outcome variables are based on self-report and not clinical or objective evaluations. </plain></SENT>
<SENT sid="630" pm="."><plain>Self-reported fatigue on the Chalder Fatigue Questionnaire was used as a cut-off for fatigue, opposed to a clinical examination, semi-structured interviews or fitness tests. </plain></SENT>
<SENT sid="631" pm="."><plain>Thus, the participants' results may not be generalizable to the group of patients who meet the full diagnostic criteria for CFS. </plain></SENT>
<SENT sid="632" pm="."><plain>However, the mean pre-treatment scores on Chalder Fatigue Scale are in line with other studies of patients with diagnosed CFS (White et al., 2011), and systematic reviews have argued that symptom measures are the best way to evaluate interventions in chronic fatigue (Brurberg et al., 2014). </plain></SENT>
<SENT sid="633" pm="."><plain>We did not have data on menopause/perimenopause status in our particpants, which could be considered a limitation since this can affect variables measured. </plain></SENT>
<SENT sid="634" pm="."><plain>It is also a limitation that subjective cognitive impairments were assessed by a questionnaire not an semi-structured interview, however, this is a common way of estimating such impairments. </plain></SENT>
<SENT sid="635" pm="."><plain>Moreover, with approximately 10% of participants reporting an emotional disorder on SCID-I, this might influence the data on maladaptive metacognitions, as these are prevalent in anxiety and depression. </plain></SENT>
<SENT sid="636" pm="."><plain>Finally, it is a limitation that 27% of patients' were excluded because of missing data, and this may have influenced our results. </plain></SENT>
</text></p></sec></SecTag><SecTag type="CONCL"><sec sec-type="conclusions" id="s6"><title><text><SENT sid="637" pm="."><plain>Conclusion </plain></SENT>
</text></title><p><text><SENT sid="638" pm="."><plain>This non-controlled study reports significant associations between dysfunctional metacognitive beliefs and subjective cognitive impairments in chronically fatigued patients. </plain></SENT>
<SENT sid="639" pm="."><plain>These associations highlight the potential importance of targeting maladaptive metacognitive beliefs in chronic fatigue. </plain></SENT>
<SENT sid="640" pm="."><plain>Finally, our results give cause to investigate metacognitive therapy as a potential supplemental or novel psychological treatment for CFS. </plain></SENT>
</text></p></sec></SecTag><SecTag type="AUTH_CONT"><sec id="s7"><title><text><SENT sid="641" pm="."><plain>Author contributions </plain></SENT>
</text></title><p><text><SENT sid="642" pm="."><plain>We all have participated in the conception of this report and have assisted in revising the manuscript for important intellectual content. </plain></SENT>
<SENT sid="643" pm="."><plain>We have all provided final approval of the enclosed report. </plain></SENT>
<SENT sid="644" pm="."><plain>More specifically: JA assisted with conceptual framework and writing as well as organized the data collection. </plain></SENT>
<SENT sid="645" pm="."><plain>PB was the project leader and essential in data collection as well as writing the methods and introduction. </plain></SENT>
<SENT sid="646" pm="."><plain>NL co-developed the experimental design, study aims and contributed to the discussion. </plain></SENT>
<SENT sid="647" pm="."><plain>TS supervised the entire production of the manuscript, co-developed the design, helped write the study aims and contributed to the introduction, results and discussion. </plain></SENT>
</text></p></sec></SecTag><SecTag type="ACK_FUND"><sec id="s8"><title><text><SENT sid="648" pm="."><plain>Funding </plain></SENT>
</text></title><p><text4fund><text><SENT sid="649" pm="."><plain>This study was done using government funding through the Central Norway Regional Health Authority. </plain></SENT>
<SENT sid="650" pm="."><plain>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. </plain></SENT>
</text></text4fund></p><sec><title><text><SENT sid="651" pm="."><plain>Conflict of interest statement </plain></SENT>
</text></title><p><text4fund><text><SENT sid="652" pm="."><plain>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. </plain></SENT>
</text></text4fund></p></sec></sec></SecTag></body><back><SecTag type="REF"><ref-list><title>References</title><ref id="B1"><text><SENT sid="653" pm="."><plain>BastienC. </plain></SENT>
<SENT sid="654" pm="."><plain>H.VallieresA.MorinC. </plain></SENT>
<SENT sid="655" pm="."><plain>M. (2001). Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med. 2, 297–307. 10.1016/S1389-9457(00)00065-4<?supplied-pmid 11438246?>11438246 </plain></SENT>
</text></ref><ref id="B2"><text><SENT sid="656" pm="."><plain>BjellandI.DahlA. </plain></SENT>
<SENT sid="657" pm="."><plain>A.HaugT. </plain></SENT>
<SENT sid="658" pm="."><plain>T.NeckelmannD. (2002). The validity of the hospital anxiety and depression scale: an updated literature review. J. </plain></SENT>
<SENT sid="659" pm="."><plain>Psychosom. </plain></SENT>
<SENT sid="660" pm="."><plain>Res. 52, 69–77. 10.1016/S0022-3999(01)00296-3<?supplied-pmid 11832252?>11832252 </plain></SENT>
</text></ref><ref id="B3"><text><SENT sid="661" pm="."><plain>BoksemM. </plain></SENT>
<SENT sid="662" pm="."><plain>A.TopsM. (2008). Mental fatigue: costs and benefits. Brain Res. </plain></SENT>
<SENT sid="663" pm="."><plain>Rev. 59, 125–139. 10.1016/j.brainresrev.2008.07.001<?supplied-pmid 18652844?>18652844 </plain></SENT>
</text></ref><ref id="B4"><text><SENT sid="664" pm="."><plain>BrosschotJ. </plain></SENT>
<SENT sid="665" pm="."><plain>F.GerinW.ThayerJ. </plain></SENT>
<SENT sid="666" pm="."><plain>F. (2006). The perseverative cognition hypothesis: a review of worry, prolonged stress-related physiological activation, and health. J. </plain></SENT>
<SENT sid="667" pm="."><plain>Psychosom. </plain></SENT>
<SENT sid="668" pm="."><plain>Res. 60, 113–124. 10.1016/j.jpsychores.2005.06.074<?supplied-pmid 16439263?>16439263 </plain></SENT>
</text></ref><ref id="B5"><text><SENT sid="669" pm="."><plain>BrowningM.HolmesE. </plain></SENT>
<SENT sid="670" pm="."><plain>A.HarmerC. </plain></SENT>
<SENT sid="671" pm="."><plain>J. (2010). The modification of attentional bias to emotional information: a review of the techniques, mechanisms, and relevance to emotional disorders. Cogn. </plain></SENT>
<SENT sid="672" pm="."><plain>Affect. </plain></SENT>
<SENT sid="673" pm="."><plain>Behav. </plain></SENT>
<SENT sid="674" pm="."><plain>Neurosci. 10, 8–20. 10.3758/CABN.10.1.8<?supplied-pmid 20233952?>20233952 </plain></SENT>
</text></ref><ref id="B6"><text><SENT sid="675" pm="."><plain>BrurbergK. </plain></SENT>
<SENT sid="676" pm="."><plain>G.FønhusM. </plain></SENT>
<SENT sid="677" pm="."><plain>S.LarunL.FlottorpS.MalterudK. (2014). Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review. BMJ Open 4:e003973. 10.1136/bmjopen-2013-003973<?supplied-pmid 24508851?>24508851 </plain></SENT>
</text></ref><ref id="B7"><text><SENT sid="678" pm="."><plain>CastellB. </plain></SENT>
<SENT sid="679" pm="."><plain>D.KazantzisN.Moss−MorrisR. </plain></SENT>
<SENT sid="680" pm="."><plain>E. (2011). Cognitive behavioral therapy and graded exercise for chronic fatigue syndrome: a meta−analysis. Clin. </plain></SENT>
<SENT sid="681" pm="."><plain>Psychol. </plain></SENT>
<SENT sid="682" pm="."><plain>Sci. </plain></SENT>
<SENT sid="683" pm="."><plain>Pract. 18, 311–324. 10.1111/j.1468-2850.2011.01262.x </plain></SENT>
</text></ref><ref id="B8"><text><SENT sid="684" pm="."><plain>ChalderT.BerelowitzG.PawlikowskaT.WattsL.WesselyS.WrightD.. </plain></SENT>
<SENT sid="685" pm="."><plain>(1993). Development of a fatigue scale. J. </plain></SENT>
<SENT sid="686" pm="."><plain>Psychosom. </plain></SENT>
<SENT sid="687" pm="."><plain>Res. 37, 147–153. 10.1016/0022-3999(93)90081-P<?supplied-pmid 8463991?>8463991 </plain></SENT>
</text></ref><ref id="B9"><text><SENT sid="688" pm="."><plain>CockshellS. </plain></SENT>
<SENT sid="689" pm="."><plain>J.MathiasJ. </plain></SENT>
<SENT sid="690" pm="."><plain>L. (2014). Cognitive functioning in people with chronic fatigue syndrome: a comparison between subjective and objective measures. Neuropsychology 28, 394. 10.1037/neu0000025<?supplied-pmid 24364389?>24364389 </plain></SENT>
</text></ref><ref id="B10"><text><SENT sid="691" pm="."><plain>CookD. </plain></SENT>
<SENT sid="692" pm="."><plain>B.O'ConnorP. </plain></SENT>
<SENT sid="693" pm="."><plain>J.LangeG.SteffenerJ. (2007). Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls. Neuroimage 36, 108–122. 10.1016/j.neuroimage.2007.02.033<?supplied-pmid 17408973?>17408973 </plain></SENT>
</text></ref><ref id="B11"><text><SENT sid="694" pm="."><plain>DendyC.CooperM.SharpeM. (2001). Interpretation of symptoms in chronic fatigue syndrome. Behav. </plain></SENT>
<SENT sid="695" pm="."><plain>Res. </plain></SENT>
<SENT sid="696" pm="."><plain>Ther. 39, 1369–1380. 10.1016/S0005-7967(00)00116-9<?supplied-pmid 11686271?>11686271 </plain></SENT>
</text></ref><ref id="B12"><text><SENT sid="697" pm="."><plain>DimaggioG.CarcioneA.SalvatoreG.SemerariA.NicoloG. (2010). A rational model for maximizing the effects of therapeutic relationship regulation in personality disorders with poor metacognition and over−regulation of affects. Psychol. </plain></SENT>
<SENT sid="698" pm="."><plain>Psychother. 83, 363–384. 10.1348/147608310X485256<?supplied-pmid 25268484?>25268484 </plain></SENT>
</text></ref><ref id="B13"><text><SENT sid="699" pm="."><plain>DobbsB. </plain></SENT>
<SENT sid="700" pm="."><plain>M.DobbsA. </plain></SENT>
<SENT sid="701" pm="."><plain>R.KissI. (2001). Working memory deficits associated with chronic fatigue syndrome. J. </plain></SENT>
<SENT sid="702" pm="."><plain>Int. </plain></SENT>
<SENT sid="703" pm="."><plain>Neuropsychol. </plain></SENT>
<SENT sid="704" pm="."><plain>Soc. 7, 285–293. 10.1017/S1355617701733024<?supplied-pmid 11311029?>11311029 </plain></SENT>
</text></ref><ref id="B14"><text><SENT sid="705" pm="."><plain>FernieB. </plain></SENT>
<SENT sid="706" pm="."><plain>A.MurphyG.WellsA.NikčevićA. </plain></SENT>
<SENT sid="707" pm="."><plain>V.SpadaM. </plain></SENT>
<SENT sid="708" pm="."><plain>M. (2015). Treatment outcome and metacognitive change in CBT and GET for chronic fatigue syndrome. Behav. </plain></SENT>
<SENT sid="709" pm="."><plain>Cogn. </plain></SENT>
<SENT sid="710" pm="."><plain>Psychother.. </plain></SENT>
<SENT sid="711" pm="."><plain>[Epub ahead of print]. 10.1017/S135246581500017X<?supplied-pmid 25895437?>25895437 </plain></SENT>
</text></ref><ref id="B15"><text><SENT sid="712" pm="."><plain>FimlandM. </plain></SENT>
<SENT sid="713" pm="."><plain>S.VasseljenO.GismervikS.RiseM. </plain></SENT>
<SENT sid="714" pm="."><plain>B.HalsteinliV.JacobsenH. </plain></SENT>
<SENT sid="715" pm="."><plain>B. (2014). Occupational rehabilitation programs for musculoskeletal pain and common mental health disorders: study protocol of a randomized controlled trial. BMC Public Health 14:368. 10.1186/1471-2458-14-368<?supplied-pmid 24735616?>24735616 </plain></SENT>
</text></ref><ref id="B16"><text><SENT sid="716" pm="."><plain>FischlerB.CluydtsR.De GuchtV.KaufmanL.De MeirleirK. (1997). Generalized anxiety disorder in chronic fatigue syndrome. Acta Psychiatr. </plain></SENT>
<SENT sid="717" pm="."><plain>Scand. 95, 405–413. 10.1111/j.1600-0447.1997.tb09653.x<?supplied-pmid 9197905?>9197905 </plain></SENT>
</text></ref><ref id="B17"><text><SENT sid="718" pm="."><plain>FuentesK.HunterM. </plain></SENT>
<SENT sid="719" pm="."><plain>A.StraussE.HultschD. </plain></SENT>
<SENT sid="720" pm="."><plain>F. (2001). Intraindividual variability in cognitive performance in persons with chronic fatigue syndrome. Clin. </plain></SENT>
<SENT sid="721" pm="."><plain>Neuropsychol. 15, 210–227. 10.1076/clin.15.2.210.1896<?supplied-pmid 11528543?>11528543 </plain></SENT>
</text></ref><ref id="B18"><text><SENT sid="722" pm="."><plain>FukudaK.StrausS. </plain></SENT>
<SENT sid="723" pm="."><plain>E.HickieI.SharpeM. </plain></SENT>
<SENT sid="724" pm="."><plain>C.DobbinsJ. </plain></SENT>
<SENT sid="725" pm="."><plain>G.KomaroffA. (1994). The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. </plain></SENT>
<SENT sid="726" pm="."><plain>Intern. </plain></SENT>
<SENT sid="727" pm="."><plain>Med. 121, 953–959. 10.7326/0003-4819-121-12-199412150-00009<?supplied-pmid 7978722?>7978722 </plain></SENT>
</text></ref><ref id="B19"><text><SENT sid="728" pm="."><plain>FunahashiS. (2001). Neuronal mechanisms of executive control by the prefrontal cortex. Neurosci. </plain></SENT>
<SENT sid="729" pm="."><plain>Res. 39, 147–165. 10.1016/S0168-0102(00)00224-8<?supplied-pmid 11223461?>11223461 </plain></SENT>
</text></ref><ref id="B20"><text><SENT sid="730" pm="."><plain>HolmenJ.MidthjellK.KrügerØ.LanghammerA.HolmenT. </plain></SENT>
<SENT sid="731" pm="."><plain>L.BratbergG. </plain></SENT>
<SENT sid="732" pm="."><plain>H. (2003). The Nord-Trøndelag health study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk. </plain></SENT>
<SENT sid="733" pm="."><plain>Epidemiol. 13, 19–32. </plain></SENT>
</text></ref><ref id="B21"><text><SENT sid="734" pm="."><plain>HolmesG. </plain></SENT>
<SENT sid="735" pm="."><plain>P.KaplanJ. </plain></SENT>
<SENT sid="736" pm="."><plain>E.GantzN. </plain></SENT>
<SENT sid="737" pm="."><plain>M.KomaroffA. </plain></SENT>
<SENT sid="738" pm="."><plain>L.SchonbergerL. </plain></SENT>
<SENT sid="739" pm="."><plain>B.StrausS. </plain></SENT>
<SENT sid="740" pm="."><plain>E.. </plain></SENT>
<SENT sid="741" pm="."><plain>(1988). Chronic fatigue syndrome: a working case definition. Ann. </plain></SENT>
<SENT sid="742" pm="."><plain>Intern. </plain></SENT>
<SENT sid="743" pm="."><plain>Med. 108, 387–389. 10.7326/0003-4819-108-3-387<?supplied-pmid 2829679?>2829679 </plain></SENT>
</text></ref><ref id="B22"><text><SENT sid="744" pm="."><plain>HouR.Moss-MorrisR.BradleyB. </plain></SENT>
<SENT sid="745" pm="."><plain>P.PevelerR.MoggK. (2008). Attentional bias towards health-threat information in chronic fatigue syndrome. J. </plain></SENT>
<SENT sid="746" pm="."><plain>Psychosom. </plain></SENT>
<SENT sid="747" pm="."><plain>Res. 65, 47–50. 10.1016/j.jpsychores.2008.03.008<?supplied-pmid 18582611?>18582611 </plain></SENT>
</text></ref><ref id="B23"><text><SENT sid="748" pm="."><plain>JacobsenH. </plain></SENT>
<SENT sid="749" pm="."><plain>B.BjorngaardJ. </plain></SENT>
<SENT sid="750" pm="."><plain>H.HaraK. </plain></SENT>
<SENT sid="751" pm="."><plain>W.BorchgrevinkP. </plain></SENT>
<SENT sid="752" pm="."><plain>C.WoodhouseA.LandroN. </plain></SENT>
<SENT sid="753" pm="."><plain>I.. </plain></SENT>
<SENT sid="754" pm="."><plain>(2014). The role of stress in absenteeism: cortisol responsiveness among patients on long-term sick leave. PLoS ONE 9:e96048. 10.1371/journal.pone.0096048<?supplied-pmid 24788346?>24788346 </plain></SENT>
</text></ref><ref id="B24"><text><SENT sid="755" pm="."><plain>JasonL. </plain></SENT>
<SENT sid="756" pm="."><plain>A.RichmanJ. </plain></SENT>
<SENT sid="757" pm="."><plain>A.RademakerA. </plain></SENT>
<SENT sid="758" pm="."><plain>W.JordanK. </plain></SENT>
<SENT sid="759" pm="."><plain>M.PlioplysA. </plain></SENT>
<SENT sid="760" pm="."><plain>V.TaylorR. </plain></SENT>
<SENT sid="761" pm="."><plain>R.. </plain></SENT>
<SENT sid="762" pm="."><plain>(1999). A community-based study of chronic fatigue syndrome. Arch. </plain></SENT>
<SENT sid="763" pm="."><plain>Intern. </plain></SENT>
<SENT sid="764" pm="."><plain>Med. 159, 2129–2137. 10.1001/archinte.159.18.2129<?supplied-pmid 10527290?>10527290 </plain></SENT>
</text></ref><ref id="B25"><text><SENT sid="765" pm="."><plain>JasonL. </plain></SENT>
<SENT sid="766" pm="."><plain>A.Torres-HardingS. </plain></SENT>
<SENT sid="767" pm="."><plain>R.JurgensA.HelgersonJ. (2004). Comparing the Fukuda et al. criteria and the Canadian case definition for chronic fatigue syndrome. J. </plain></SENT>
<SENT sid="768" pm="."><plain>Chron. </plain></SENT>
<SENT sid="769" pm="."><plain>Fatigue Syndr. 12, 37–52. 10.1300/J092v12n01_03 </plain></SENT>
</text></ref><ref id="B26"><text><SENT sid="770" pm="."><plain>KallestadH.JacobsenH. </plain></SENT>
<SENT sid="771" pm="."><plain>B.LandrøN. </plain></SENT>
<SENT sid="772" pm="."><plain>I.BorchgrevinkP. </plain></SENT>
<SENT sid="773" pm="."><plain>C.StilesT. </plain></SENT>
<SENT sid="774" pm="."><plain>C. (2015). The role of insomnia in the treatment of chronic fatigue. J. </plain></SENT>
<SENT sid="775" pm="."><plain>Psychosom. </plain></SENT>
<SENT sid="776" pm="."><plain>Res. 78, 427–432. 10.1016/j.jpsychores.2014.11.022<?supplied-pmid 25498318?>25498318 </plain></SENT>
</text></ref><ref id="B27"><text><SENT sid="777" pm="."><plain>LandmarkT.RomundstadP.DaleO.BorchgrevinkP. </plain></SENT>
<SENT sid="778" pm="."><plain>C.KaasaS. (2012). Estimating the prevalence of chronic pain: validation of recall against longitudinal reporting (the HUNT pain study). Pain 153, 1368–1373. 10.1016/j.pain.2012.02.004<?supplied-pmid 22575226?>22575226 </plain></SENT>
</text></ref><ref id="B28"><text><SENT sid="779" pm="."><plain>LogeJ. </plain></SENT>
<SENT sid="780" pm="."><plain>H.EkebergO.KaasaS. (1998). Fatigue in the general Norwegian population: normative data and associations. J. </plain></SENT>
<SENT sid="781" pm="."><plain>Psychosom. </plain></SENT>
<SENT sid="782" pm="."><plain>Res. 45, 53–65. 10.1016/S0022-3999(97)00291-2<?supplied-pmid 9720855?>9720855 </plain></SENT>
</text></ref><ref id="B29"><text><SENT sid="783" pm="."><plain>Maher-EdwardsL.FernieB. </plain></SENT>
<SENT sid="784" pm="."><plain>A.MurphyG.WellsA.SpadaM. </plain></SENT>
<SENT sid="785" pm="."><plain>M. (2011). Metacognitions and negative emotions as predictors of symptom severity in chronic fatigue syndrome. J. </plain></SENT>
<SENT sid="786" pm="."><plain>Psychosom. </plain></SENT>
<SENT sid="787" pm="."><plain>Res. 70, 311–317. 10.1016/j.jpsychores.2010.09.016<?supplied-pmid 21414450?>21414450 </plain></SENT>
</text></ref><ref id="B30"><text><SENT sid="788" pm="."><plain>MarenS. (2007). The threatened brain. Science 317, 1043. 10.1126/science.1147797<?supplied-pmid 17717174?>17717174 </plain></SENT>
</text></ref><ref id="B31"><text><SENT sid="789" pm="."><plain>McCroneP.DarbishireL.RidsdaleL.SeedP. (2003). The economic cost of chronic fatigue and chronic fatigue syndrome in UK primary care. Psychol. </plain></SENT>
<SENT sid="790" pm="."><plain>Med. 33, 253–261. 10.1017/S0033291702006980<?supplied-pmid 12622304?>12622304 </plain></SENT>
</text></ref><ref id="B32"><text><SENT sid="791" pm="."><plain>MichielsV.CluydtsR. (2001). Neuropsychological functioning in chronic fatigue syndrome: a review. Acta Psychiatr. </plain></SENT>
<SENT sid="792" pm="."><plain>Scand. 103, 84–93. 10.1034/j.1600-0447.2001.00017.x<?supplied-pmid 11167310?>11167310 </plain></SENT>
</text></ref><ref id="B33"><text><SENT sid="793" pm="."><plain>MiyakeA.FriedmanN. </plain></SENT>
<SENT sid="794" pm="."><plain>P. (2012). The nature and organization of individual differences in executive functions four general conclusions. Curr. </plain></SENT>
<SENT sid="795" pm="."><plain>Dir. </plain></SENT>
<SENT sid="796" pm="."><plain>Psychol. </plain></SENT>
<SENT sid="797" pm="."><plain>Sci. 21, 8–14. 10.1177/0963721411429458<?supplied-pmid 22773897?>22773897 </plain></SENT>
</text></ref><ref id="B34"><text><SENT sid="798" pm="."><plain>MorinC. </plain></SENT>
<SENT sid="799" pm="."><plain>M.BellevilleG.BélangerL.IversH. (2011). The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 34, 601–608. <?supplied-pmid 21532953?>21532953 </plain></SENT>
</text></ref><ref id="B35"><text><SENT sid="800" pm="."><plain>Nolen-HoeksemaS. (2000). The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. J. </plain></SENT>
<SENT sid="801" pm="."><plain>Abnorm. </plain></SENT>
<SENT sid="802" pm="."><plain>Psychol. 109:504. 10.1037/0021-843X.109.3.504<?supplied-pmid 11016119?>11016119 </plain></SENT>
</text></ref><ref id="B36"><text><SENT sid="803" pm="."><plain>QuerstretD.CropleyM. (2012). Exploring the relationship between work-related rumination, sleep quality, and work-related fatigue. J. </plain></SENT>
<SENT sid="804" pm="."><plain>Occup. </plain></SENT>
<SENT sid="805" pm="."><plain>Health Psychol. 17, 341–353. 10.1037/a0028552<?supplied-pmid 22746369?>22746369 </plain></SENT>
</text></ref><ref id="B37"><text><SENT sid="806" pm="."><plain>RayC.JefferiesS.WeirW. </plain></SENT>
<SENT sid="807" pm="."><plain>R. </plain></SENT>
<SENT sid="808" pm="."><plain>C. (1997). Coping and other predictors of outcome in chronic fatigue syndrome: A 1-year follow-up. J. </plain></SENT>
<SENT sid="809" pm="."><plain>Psychosom. </plain></SENT>
<SENT sid="810" pm="."><plain>Res. 43, 405–415. 10.1016/S0022-3999(97)00111-6<?supplied-pmid 9330240?>9330240 </plain></SENT>
</text></ref><ref id="B38"><text><SENT sid="811" pm="."><plain>RoyleJ.LincolnN. </plain></SENT>
<SENT sid="812" pm="."><plain>B. (2008). The everyday memory questionnaire-revised: development of a 13-item scale. Disabil. </plain></SENT>
<SENT sid="813" pm="."><plain>Rehabil. 30, 114–121. 10.1080/09638280701223876<?supplied-pmid 17852284?>17852284 </plain></SENT>
</text></ref><ref id="B39"><text><SENT sid="814" pm="."><plain>SharpeM.ArchardL.BanatvalaJ.BorysiewiczL.ClareA.DavidA.. </plain></SENT>
<SENT sid="815" pm="."><plain>(1991). A report–chronic fatigue syndrome: guidelines for research. J. </plain></SENT>
<SENT sid="816" pm="."><plain>R. </plain></SENT>
<SENT sid="817" pm="."><plain>Soc. </plain></SENT>
<SENT sid="818" pm="."><plain>Med. 84, 118. <?supplied-pmid 1999813?>1999813 </plain></SENT>
</text></ref><ref id="B40"><text><SENT sid="819" pm="."><plain>ShimamuraA. </plain></SENT>
<SENT sid="820" pm="."><plain>P. (2000). Toward a cognitive neuroscience of metacognition. Conscious. </plain></SENT>
<SENT sid="821" pm="."><plain>Cogn. 9, 313–323. 10.1006/ccog.2000.0450<?supplied-pmid 10924251?>10924251 </plain></SENT>
</text></ref><ref id="B41"><text><SENT sid="822" pm="."><plain>WareJ.KosinskiM.DeweyJ.GandekB. (2001). How to Score and Interpret Single-Item Health Status Measures : A Manual for Users of the of the SF-8 Health Survey : (With a Supplement on the SF-6 Health Survey). Lincoln, RI: QualityMetric, Inc. </plain></SENT>
</text></ref><ref id="B42"><text><SENT sid="823" pm="."><plain>WeardenA.ApplebyL. (1997). Cognitive performance and complaints of cognitive impairment in chronic fatigue syndrome (CFS). Psychol. </plain></SENT>
<SENT sid="824" pm="."><plain>Med. 27, 81–90. 10.1017/S0033291796004035<?supplied-pmid 9122311?>9122311 </plain></SENT>
</text></ref><ref id="B43"><text><SENT sid="825" pm="."><plain>WellsA. (2005). The metacognitive model of GAD: assessment of meta-worry and relationship with DSM-IV generalized anxiety disorder. Cognit. </plain></SENT>
<SENT sid="826" pm="."><plain>Ther. </plain></SENT>
<SENT sid="827" pm="."><plain>Res. 29, 107–121. 10.1007/s10608-005-1652-0 </plain></SENT>
</text></ref><ref id="B44"><text><SENT sid="828" pm="."><plain>WellsA. (2011). Metacognitive Therapy for Anxiety and Depression. New York, NY: Guilford Press. </plain></SENT>
</text></ref><ref id="B45"><text><SENT sid="829" pm="."><plain>WellsA.Cartwright-HattonS. (2004). A short form of the metacognitions questionnaire: properties of the MCQ-30. Behav. </plain></SENT>
<SENT sid="830" pm="."><plain>Res. </plain></SENT>
<SENT sid="831" pm="."><plain>Ther. 42, 385–396. 10.1016/S0005-7967(03)00147-5<?supplied-pmid 14998733?>14998733 </plain></SENT>
</text></ref><ref id="B46"><text><SENT sid="832" pm="."><plain>WellsA.FisherP.MyersS.WheatleyJ.PatelT.BrewinC. </plain></SENT>
<SENT sid="833" pm="."><plain>R.. </plain></SENT>
<SENT sid="834" pm="."><plain>(2012). Metacognitive therapy in treatment-resistant depression: a platform trial. Behav. </plain></SENT>
<SENT sid="835" pm="."><plain>Res. </plain></SENT>
<SENT sid="836" pm="."><plain>Ther. 50, 367–373. 10.1016/j.brat.2012.02.004<?supplied-pmid 22498310?>22498310 </plain></SENT>
</text></ref><ref id="B47"><text><SENT sid="837" pm="."><plain>WellsA.MatthewsG. (1996). Modelling cognition in emotional disorder: the S-REF model. Behav. </plain></SENT>
<SENT sid="838" pm="."><plain>Res. </plain></SENT>
<SENT sid="839" pm="."><plain>Ther. 34, 881–888. 10.1016/S0005-7967(96)00050-2<?supplied-pmid 8990539?>8990539 </plain></SENT>
</text></ref><ref id="B48"><text><SENT sid="840" pm="."><plain>WhiteP. </plain></SENT>
<SENT sid="841" pm="."><plain>D.GoldsmithK. </plain></SENT>
<SENT sid="842" pm="."><plain>A.JohnsonA. </plain></SENT>
<SENT sid="843" pm="."><plain>L.PottsL.WalwynR.DeCesareJ. </plain></SENT>
<SENT sid="844" pm="."><plain>C.. </plain></SENT>
<SENT sid="845" pm="."><plain>(2011). Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 377, 823–836. 10.1016/S0140-6736(11)60096-2<?supplied-pmid 21334061?>21334061 </plain></SENT>
</text></ref><ref id="B49"><text><SENT sid="846" pm="."><plain>ZigmondA. </plain></SENT>
<SENT sid="847" pm="."><plain>S.SnaithR. </plain></SENT>
<SENT sid="848" pm="."><plain>P. (1983). The hospital anxiety and depression scale. Acta Psychiatr. </plain></SENT>
<SENT sid="849" pm="."><plain>Scand. 67, 361–370. 10.1111/j.1600-0447.1983.tb09716.x<?supplied-pmid 23543730?>6880820 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
